This website uses cookies to ensure you get the best experience on our website. Privacy Policy
UroToday UroToday
  • Contact
  • Login
  • Sign Up Free
  • Transformative Evidence
    • mCRPC
      • PEACE-3 Trial
      • PROfound Trial
      • The RALU Study: Treatment Considerations in the First Line Setting of mCRPC
      • VISION Trial
    • mHSPC
      • ARANOTE Trial
      • ARASENS Trial
    • nmCRPC
      • ARAMIS Trial
    • nmCSPC
      • EMBARK Trial
    • PSMA PET Imaging
      • COBRA Trial
      • CONDOR Trial
      • OSPREY Trial
    • Bladder Cancer
      • ANKTIVA
      • Bladder Cancer Detection
      • CORE-001 Study
      • EV-302
    • Kidney Cancer
      • ZIRCON
  • Centers of Excellence
    • Urologic Oncology
      • Left Group
        • Health Policy
          • Health Policy
            Ruchika Talwar, MD
        • Bladder Cancer
          • Bladder Cancer
            Ashish Kamat, MD
          • Advanced Bladder Cancer
            Shilpa Gupta, MD
          • Trimodality Therapy
            Leslie Ballas, MD
        • Kidney Cancer
          • Advanced Kidney Cancer
            Pedro Barata, MD, MSc
        • Endourology
          • Endourology
            Jaime Landman, MD
      • Prostate Cancer
        • Localized Prostate Cancer
          Matthew R. Cooperberg, MD, MPH
        • Decipher Genomic Classifier
        • Imaging Center
          Phillip Koo, MD
        • mHSPC
          Neeraj Agarwal, FASCO, MD
        • nmCRPC
          Zachary Klaassen, MD, MSc
        • mCRPC Treatment
          A. Oliver Sartor, MD
        • PSMA-Targeted Therapy
        • Advanced Prostate Cancer
          Zachary Klaassen, MD, MSc
      • Disparities: Social Determinants of Health
        • Disparities: Social Determinants of Health
          Samuel L. Washington III, MD, MAS
      • Translational Prostate Cancer
        • Translational Science in Prostate Cancer
          Andrea Miyahira, Ph.D
        • Women in Science
          Andrea Miyahira, Ph.D
      • Upper Tract Urothelial Carcinoma
        • Upper Tract Urothelial Carcinoma
          Sam S. Chang, MD, MBA
      • TESTICULAR, PENILE & RARE GU MALIGNANCIES
        • Testicular Cancer
    • Pelvic Health & Reconstruction
      • Bladder Health
        Diane K. Newman, DNP, ANP-BC, FAAN
      • Pelvic Health
        Diane K. Newman, DNP, ANP-BC, FAAN
      • Society of Urodynamics, Female Pelvic Medicine & Urogenital Reconstruction (SUFU)
        Stephen R. Kraus, MD
      • Urologic Catheters (Includes CAUTI)
        Diane K. Newman, DNP, ANP-BC, FAAN
  • Videos
    • Exclusives
      • Conferences
      • Exclusive Collaborations
      • Independent Medical Education
      • Covid-19
      • The Prostate Cancer Foundation
      • Health Policy in Urological Diseases
      • Disparities: Social Determinants of Health
      • Practice Guidelines Reviews
    • Urologic Oncology
      • Prostate Cancer
      • Bladder Cancer
      • Kidney Cancer
      • Upper Tract Urothelial Tumors
      • Testicular Cancer
      • Endourology
    • Pelvic Health & Reconstruction
      • Pelvic Health & Reconstruction
  • Trials in Progress
    • Trials in Progress
      • Bladder Cancer
        • BOND-003 Cohort P
        • CORE-008
        • IMMORTAL
        • PIVOT-006
      • Kidney Cancer
        • RadiCal
        • SAMURAI
    • Middle Side
      • Prostate Cancer
        • ARAMON
        • ARASEC
        • ARASTEP
        • CLARIFY
        • ECLIPSE
        • ESCAPE
        • FORT
    • Right Side
      • Prostate Cancer
        • METANOVA
        • NRG-GU 0101
        • PROMISE
        • RTIRE
        • SECuRE
        • SHORTER
  • Clinical Trials
    • From the Editor
      • Search Clinical Trials
  • Articles
    • Urology (benign and malignant)
      • Urologic Oncology
      • Men's Health
      • Endourology & Stones
      • Pediatric Urology
      • COVID-19 and Genitourinary Cancers
    • Pelvic Health
      • Pelvic Health & Reconstruction
  • Conference Coverage
    • Recent Conferences
      • SUO 2024
      • SCS AUA 2024
      • ASTRO 2024
      • IBCN 2024
      • ESMO 2024
    • All Conferences
      • View All
    • Quick Takes
      • ESMO 2024
  • PCF
  1. UroToday Home
  2. Recent Abstracts
  3. Urologic Oncology

Prostate Cancer

Recent Abstracts
Pathologic findings in radical prostatectomy specimens from patients eligible for active surveillance with highly selective criteria: A multicenter study - Abstract August 15, 2012
Best practice in nurse-led chemotherapy review: A position statement from the United Kingdom Oncology Nursing Society - Abstract August 15, 2012
Trajectories and predictors of symptom occurrence, severity, and distress in prostate cancer patients undergoing radiation therapy - Abstract August 15, 2012
Use of frozen section in genitourinary pathology - Abstract August 15, 2012
Treatment with curative intent and survival in men with high-risk prostate cancer. A population-based study of 11 380 men with serum PSA level 20-100 ng/mL - Abstract August 14, 2012
Defining the impact of vascular risk factors on erectile function recovery after radical prostatectomy - Abstract August 14, 2012
Genetic predisposition to early recurrence in clinically localized prostate cancer - Abstract August 14, 2012
Short (≤ 1 mm) positive surgical margin and risk of biochemical recurrence after radical prostatectomy - Abstract August 14, 2012
The impact of socio-economic circumstances on overall and grade-specific prostate cancer incidence: A population-based study - Abstract August 14, 2012
Radical prostatectomy in clinically localized high-risk prostate cancer: Outcome of 231 consecutive patients - Abstract August 14, 2012
Feasibility of minimally invasive radical prostatectomy in prostate cancer patients with high prostate-specific antigen: Feasibility and 1-year outcomes - Abstract August 14, 2012
Automatic shape-based level set segmentation for needle tracking in 3-D TRUS-guided prostate brachytherapy - Abstract August 14, 2012
Best practices in robot-assisted radical prostatectomy: Recommendations of the Pasadena Consensus Panel - Abstract August 14, 2012
Clinical profile, quality of care, and recurrence in Arab-American and C aucasians prostate cancer patients in Michigan - Abstract August 14, 2012
Dosimetric and deformation effects of image-guided interventions during stereotactic body radiation therapy of the prostate using an endorectal balloon - Abstract August 14, 2012
Investigating the dosimetric and tumor control consequences of prostate seed loss and migration - Abstract August 14, 2012
Extended biopsy based criteria incorporating cumulative cancer length for predicting clinically insignificant prostate cancer - Abstract August 14, 2012
Long-term oncological outcomes after laparoscopic radical prostatectomy - Abstract August 14, 2012
Early detection of high-grade prostate cancer using digital rectal examination (DRE) in men with a prostate-specific antigen level of less than 2.5 ng/mL and the risk of death - Abstract August 14, 2012
Influence of opioid consumption on serum prostate-specific antigen levels in men without clinical evidence of prostate cancer - Abstract August 13, 2012
Page 1272 of 1451
  • Start
  • Prev
  • 1267
  • 1268
  • 1269
  • 1270
  • 1271
  • 1272
  • 1273
  • 1274
  • 1275
  • 1276
  • Next
  • End
  • About UroToday
  • Journals
  • Calendar
  • Editorial and Advertising Guidelines
  • Editors and Contributors
  • FAQs
  • Privacy Policy
  • Terms of Use
Follow UroToday

COPYRIGHT © 2002 - 2025 DIGITAL SCIENCE PRESS, LLC

Login

Login to update email address, newsletter preferences and use bookmarks.

  • Forgot Password?
  • Sign Up Free